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Abstract
Background: We have previously performed a genome-wide linkage study in Scandinavian Type 1 diabetes (T1D) families.
In the Swedish families, we detected suggestive linkage (LOD#2.2) to the chromosome 5p13-q13 region. The aim of our
study was to investigate the linked region in search for possible T1D susceptibility genes.
Methodology/Principal Findings: Microsatellites were genotyped in the Scandinavian families to fine-map the previously
linked region. Further, SNPs were genotyped in Swedish and Danish families as well as Swedish sporadic cases. In the
Swedish families we detected genome-wide significant linkage to the 5-hydroxytryptamine receptor 1A (HTR1A) gene (LOD
3.98, p,9.8610
26). Markers tagging two separate genes; the ring finger protein 180 (RNF180) and HTR1A showed association
to T1D in the Swedish and Danish families (p,0.002, p,0.001 respectively). The association was not confirmed in sporadic
cases. Conditional analysis indicates that the primary association was to HTR1A. Quantitative PCR show that transcripts of
both HTR1A and RNF180 are present in human islets of Langerhans. Moreover, immunohistochemical analysis confirmed the
presence of the 5-HTR1A protein in isolated human islets of Langerhans as well as in sections of human pancreas.
Conclusions: We have identified and confirmed the association of both HTR1A and RFN180, two genes in high linkage
disequilibrium (LD) to T1D in two separate family materials. As both HTR1A and RFN180 were expressed at the mRNA level
and HTR1A as protein in human islets of Langerhans, we suggest that HTR1A may affect T1D susceptibility by modulating
the initial autoimmune attack or either islet regeneration, insulin release, or both.
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Introduction
The incidence of Type 1 diabetes (T1D) is rapidly increasing
around the world [1] and Sweden has one of the highest incidence
rates of T1D [2]. T1D is an autoimmune disease which is
characterised by gradual destruction of insulin producing beta-
cells located in the pancreas.
The detailed aetiology of T1D is still unknown, yet it is
understood that both environmental and genetic factors contribute
to disease susceptibility. Studies have identified more than 40
susceptibility loci for T1D [3]. The Major Histocompatibility Complex
(MHC) on chromosome 6 is known to be the key T1D
susceptibility region accounting for more than 50% of the total
genetic risk. Other T1D susceptibility genes include the insulin
gene (chromosome 11p5), the CTLA-4 gene (chromosome 2q33),
IL2RA (chromosome 10p15), IFIH1 (chromosome 2q24) and the
PTPN22 gene (chromosome 1p13) [3]. However, the identified
PLoS ONE | www.plosone.org 1 May 2012 | Volume 7 | Issue 5 | e35439T1D susceptibility genes and gene regions do not explain all of the
genetic risk. This could be due to gene-gene and gene-
environment interactions, epigenetic effects but also due to so far
unidentified susceptibility genes.
We have in a previous genome-wide linkage study detected
suggestive linkage (LOD,2.2) to the chromosome 5p13-q13
region in a Scandinavian T1D family material [4]. In the present
study we narrowed the region of linkage and identified associated
markers in the 5-hydroxytryptamine (serotonin) receptor 1A (HTR1A) and
the ring finger protein 180 (RNF180) genes. We then confirmed this
association in independent materials. Further we have detected
HTR1A and RNF180 expression in human pancreatic islets of
Langerhans.
Methods
Ethics Statement
The ethics committees at Karolinska Insitutet, Umea ˚ Univer-
sity, Copenhagen University and Oslo University have approved
blood sampling for the purpose of genetic analyses for the current
study. Oral or written consent was obtained from the patients,
controls or their guardians.
Further, the ethics committee at Lund University has approved
the sampling of pancreases of organ donors who have approved
the use of their organs for medical research according to the organ
donor register.
Patients and Controls
Scandinavian families. The Swedish families consist of 184
multiplex and 9 simplex Swedish families, including a total of 200
affected T1D sib-pairs. The Danish family material consist of 147
multiplex and 5 simplex families with 175 affected sib-pairs, while
the Norwegian material consists of 77 multiplex and 2 simplex
families with 89 affected sib-pairs [4] (Table 1).
Diabetes Incidence Study in Sweden 2 (DISS2). The
Diabetes Incidence Study in Sweden consists of 778 patients with
diabetes and 836 matched controls identified through the diabetes
incidence study register. The incident DISS2 patients were
between 15 and 34 years. At follow-up visits 528 patients were
classified with T1D [5]. The remaining 250 patients were classified
as type 2 diabetes patients, secondary diabetes or unclassified
diabetes patients and were therefore excluded from our study.
Better Diabetes Diagnosis Study (BDD). The BDD cohort
consists of 2742 newly diagnosed diabetes patients. All patients
were less than 18 years of age at the time of diagnosis. Patients
were recruited between May 2005 and September 2009 from 40
pediatric clinics in Sweden [6]. At follow up, 95% of the patients
were classified as T1D while the remaining 5% were classified with
type 2, MODY, secondary, ‘‘other’’ or ‘‘unknown’’ type of
diabetes. All patients of non-European descent were excluded
from the cohort. In the current study we have included 2300 T1D
patients from the BDD cohort.
Multiple Sclerosis (MS) controls. We have included 527
healthy controls between the ages of 18–70 years from an ongoing
population based case control study of multiple sclerosis (MS)
called EIMS (Epidemiological Investigations in Multiple Sclerosis)
in our analysis. Controls were matched for age, gender and
residential area to incident MS cases throughout Sweden [7].
Genetic Fine-mapping of Chromosome 5
Microsatellite genotyping. Fine mapping of chromosome 5
was performed by typing microsatellites in the Scandinavian
families. A total of 40 microsatellite markers were selected from
NCBI (http://www.ncbi.nlm.nih.gov/), GDB (http://gdbwww.
gdb.org/), and Marshfield (http://research.marshfieldclinic.org/
genetics/). PCR conditions and quality controls were as described
[4].
SNP genotyping. For genotyping of Single Nucleotide
Polymorphisms (SNPs) a total of 67 SNPs were selected with an
average spacing of 10–30 kb and a minor allele frequency above
0.3. A lower rare allele frequency was only accepted for SNPs
within genes. Fifteen SNPs were chosen in possible functional
candidate T1D susceptibility genes in the 5p13-q13 region (Table
S1). All SNPs were genotyped either using Pyrosequencing
(Pyrosequence Inc., Sweden) [8] or the TaqMan method
(Applied Biosystems Inc., Sweden) as described [9].
All SNPs in the MS controls were genotyped using the
Human660-Quad chip as described [10].
DNA sequencing. Due to the lack of identified SNPs in
HTR1A, sequencing of the gene and its flanking regions was
performed using the ABI Prism 3730 Genetic Analyser method
(Applied Biosystems Inc., Sweden). DNA from six T1D patients
(four patients carrying a HTR1A T1D risk haplotype and two
carrying a non-risk haplotype) and five controls (two controls with
the T1D risk haplotype and three without) were sequenced.
Haplotypes were defined through previously typed SNPs using the
GeneHunter program. The 11 756 bp long DNA sequence was
divided into approx. 1 000 bp segments. Primer sequences are
available on request. Primers were obtained from DNA
Technology A/S (Risskov, Denmark). Sequencing was
performed in ABI the Prism 3730 Genetic Analyser and the
results were analysed in the SeqScape software, v. 2.5 (Applied
Biosystems Inc., Sweden).
Statistical Analysis
All microsatellite markers were mapped to the chromosome
5p13-q13 region using CRIMAP [11]. Mendelian consistencies,
excess of homozygosity (Hardy-Weinberg equilibrium) and allele
frequencies for the analysed SNPs and microsatellites in the
families were estimated using the zGenStat program (H. Zazzi,
unpublished). Linkage was assessed by non-parametric linkage
methods (ALLEGRO [12]). Single- and multi-point linkage
analyses were performed using the exponential model with equal
Table 1. T1D data materials.
Category Swedish Danish Norwegian
Sib pairs:
Affected 200 175 89
Unaffected 53 135 23
Discordant 277 287 123
Multiplex families 184 147 77
Simplex 9 5 2
Age at onset median
(range)
14 (0–53) 13 (0–71) 12 (1–52)
DISS2 BDD MS
Cases 778 2300 –
Controls 836 – 527
T1D at onset (%) 76.2 95 –
Age/age onset median 25 10
(range) (15–34) (0–19) (18–70)
*Only healthy controls were used from the Epidemiological Investigations in
Multiple Sclerosis (EIMS) study.
doi:10.1371/journal.pone.0035439.t001
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identifying SNPs responsible for linkage was performed in the
Linkage and Association Modeling in Pedigrees (LAMP) software
program [13]. The LD structure and tagging of SNPs were
analyzed in Haploview [14]. LD blocks were identified using all
three block definitions with similar results. Hardy-Weinberg
equilibrium was tested among controls only. Single SNP and
haplotype association as well as conditional association analysis
were assessed using the Unphased computer program (version
3.0.6) [15]. Study cohort was used as a confounder in the
combined association analyses.
Imputation
Imputation of the rs6295, rs356570 and rs6880454 SNPs
among the MS controls was performed using the MaCH v. 1.0.16
analysis program with default settings [16]. Previous SNP
genotyping results from the MS Genome wide association (GWAS)
study were used. Quality controls of typed SNPs included checking
for call-rates (per sample and per SNP), heterozygosity, recent
shared ancestry, non-European ancestry, MAF and deviation from
Hardy-Weinberg equilibrium [10].
Human Islet Donor Material
Human islets were obtained from the Nordic Network for
Clinical Transplantation, Uppsala and distributed by the Human
tissue laboratory at Lund University Diabetes Center, Malmo ¨,
Sweden.
Quantitative-PCR of HTR1A and RNF180 mRNA from
Human Islets of Langerhans
mRNA was prepared from human islets of Langerhans from a
total of 10 healthy age and gender matched donors using mRNA
Easy Plus mini kit, (Qiagen, Hilden, Germany). cDNA was
obtained by reverse transcription (Maxima
TM First Strand cDNA
Synthesis Kit, Fermentas, Thermo Scientific, Sweden). The
mRNA levels were quantified using a Probe/Rox Real-Time
PCR (Maxima
TM Probe/ROX qPCR Master Mix (2X), Fermen-
tas, Thermo Scientific, Sweden) with an ABI PRISM 7900
(Applied Biosystems, Inc., Sweden), and assays-on-demand were
employed for HTR1A (Hs 00265014) and RNF180 (Hs 00400379)
(Applied Biosystems Inc., Sweden). Each sample was run in
duplicate, and the transcript quantity was normalized to the
mRNA level of cyclophilin A (Hs 01565700, PPIA), polymerase 2 (Hs
00172187, POL2A) and hypoxanthine guanine phosphoribosyl transferase
(Hs 01003267, HPRT) (Applied Biosystems).
Tissue Preparation and Immunohistochemistry
For histochemical analyses human islets and biopsies from
human pancreas were fixed overnight in Stefanini’s solution (2%
paraformaldehyde and 0.2% picric acid in 0.1 M phosphate
buffered saline, pH 7.2), rinsed thoroughly in Tyrode solution
containing 10% sucrose and frozen on dry ice. Sections (10 mm)
were cut and thaw-mounted on slides. Antibodies were diluted in
phosphate buffered saline (pH 7.2) containing 0.25% bovine
serum albumin and 0.25% Triton X-100. Sections were incubated
with primary antibodies (goat anti- 5HTR1A; code sc-1459;
dilution 1:100 (Santa Cruz Biotech. Inc., CA USA), guinea pig
anti-proinsulin; code 9003; dilution 1:2560; EuroDiagnostica,
Malmo ¨, Sweden), and rabbit anti-glucagon; code 7811; dilution
1:5000 (EuroDiagnostica) overnight at 4uC in moisturizing
chambers. The specificity of immunostaining was tested using
primary antisera pre-absorbed with homologous antigen (100 mg
of peptide per ml antiserum at working dilution). Immunofluores-
cence was examined in an epi-fluorescence microscope (Olympus,
B660). By changing filters the location of the different secondary
antibodies in double staining was determined. Images were
captured with a digital camera (Nikon DS-2Mv).
Computational Analysis
The web based software RAVEN (www.cisreg.ca/cgi-bin/
RAVEN/a) was used for detecting potential transcription factor
binding sites.
Results
Fine-mapping of Chromosome 5p13-q13 and HTR1A
Sequencing
The region on chromosome 5 (5p13-q13) which previously
showed suggestive linkage [4] was narrowed down by genotyping
additional microsatellites and SNPs located in the area, in separate
cohorts.
We first typed an additional 36 microsatellites in the
Scandinavian families. A region of 20.6 cM between the
microsatellites D5S407 and D5S428 showed strongest support
for linkage (LOD 2.16, p,0.0008). In the single point analysis,
using the exponential equal weighting model, D5S2048 reached a
LOD of 2.97 (p,0.0002). The added evidence for linkage to this
region provided by the Danish and Norwegian families was
modest (LOD 0.68 p,0.04 and LOD 0.22 p,0.16). We therefore
decided to perform further analysis in the Swedish families by
typing four additional microsatellites. D5S2000 showed strongest
linkage in a multipoint analyses (LOD 2.70, approx 41.5 cM,
Figure 1a).
We next chose to genotype 61 evenly distributed SNPs across
the 50 695 kb–63 532 kb region which was the region showing
strongest evidence of linkage. Genotyping results revealed three
linked regions (Figure 1a). The region showing strongest linkage
(5p13-q13) contained the HTR1A gene. Two SNPs; rs878567 and
rs6295, which are located on either side of HTR1A, displayed
genome wide significant linkage of LOD 3.98, p,9.8610
26 and
LOD 3.66, p,2610
25 (Figure 1a). Also, rs749099 located
downstream of HTR1A showed significant linkage (LOD 3.78,
p,1.5610
25).
In the Swedish families, significant association was observed for
the rs6295 SNP (p,0.01) which is located in very close proximity
to HTR1A (1019 bp upstream of HTR1A). Also, several other
SNPs in the HTR1A region showed association to T1D (Table 2
and Figure 1b), suggesting that HTR1A is a T1D susceptibility
gene. Additionally, it was seen that rs356570, 190 kb upstream of
HTR1A is associated to T1D (p,0.002).
When the LAMP software was used to confirm our observed
linkage for rs6295, suggestive linkage of LOD 2.4 (p,0.01) was
observed for the rs6295 SNP. Further, when test for association
was performed for rs6295 a LOD of 3.1 and p,1.6610
24 was
observed, suggesting that this SNP is responsible for the observed
linkage.
No SNPs in the coding sequence of HTR1A were found in
Ensemble or dbSNP. Therefore, in the search for possible
unidentified SNPs, sequencing of the HTR1A gene and promoter
was carried out. In an 11 756 bp long region around HTR1A,w e
sequenced 9 low risk haplotypes and 10 high risk haplotypes
identified by haplotype association in the Swedish famililes.
Through the sequencing, six previously identified and genotyped
SNPs (rs1364043, rs1423691, rs749099, rs878567, rs6449693 and
rs6295) were confirmed. Further, three SNPs which had not been
published in a public data base at the time of the study, were
identified (rs1364043, rs970453 and rs749098) and genotyped in
HTR1A a Novel Type 1 Diabetes Susceptibility Gene
PLoS ONE | www.plosone.org 3 May 2012 | Volume 7 | Issue 5 | e35439Figure 1. a–b. Linkage and association analysis in Scandinavian families and case-control cohort. Linkage analysis of T1D on chromsome
5 in Swedish, -Danish and -Norwegian multiplex families (a). The dashed line represents multipoint linkage from the original scan in the Swedish,
Danish and Norwegian families [4]. The thin dark grey line represents the ‘‘fine mapping’’ including 36 microsatellites in all Scandinavian families. A
region between D5S407 and D5S428 (at approx 41.5 cM in figure) showed a linkage of LOD 2.16. The dotted line represents the Swedish families
using all 40 microsattelites (multipoint). Here, D5S2000 showed strongest linkage (LOD 2.70). The black diamonds represent the ‘‘fine mapping’’
single point analysis in the Swedish families. In the singlepoint analysis for the Swedish families, D5S2048 showed strong linkage (LOD 2.97). The
black thick line represents linkage in Swedish families to T1D on chromosome using an extra 4 microsattelites and 61 SNPs, reveiling three linked
peaks where the most strongly linked region was the 5p13-q13 (at approx 43 cM on figure) region (LOD 2.7 for rs6295). In the singlepoint analysis
using all 61 SNPs and 4 extra microsattelites (white diamonds) rs878567 and rs6295 showed genome-wide significant linkage (LOD 3.9 and LOD 3.65
respectively). Linkage was calculated using the Exponential Equal Weighting model in the Allegro program.SNP association for the Swedish sporadic
cases and controls and Swedish and Danish multiplex families (b) was calculated from rs1158292 (63 001 317 bp) to rs6880454 (63 5028 02 bp).
Swedish families (diamonds). Danish families (squares), DISS2 (triangles) and BDD (crosses). Association analysis was carried out in the Unphased
program. For the BDD cohort, association was calculated using controls included in the Swedish (MS) EIMS study.
doi:10.1371/journal.pone.0035439.g001
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identification, it was seen that all of these SNPs are located within
the same LD block (Figure 2). No SNPs in the coding sequence of
the HTR1A gene were identified.
Using the Haploview program and genotypes in the 63 280 kb
to 63 560 kb region from individuals with European ancestry from
the HapMap project, we saw that rs356570 tags for 71 SNPs
located further upstream of HTR1A. A number of these SNPs are
located within or around the RNF180 gene, suggesting that this
gene could be involved in T1D susceptibility as well. It was also
seen that the region between HTR1A and RNF180 has very high
LD (Figure 2).
To test the involvement of RNF180 in the susceptibility to T1D,
another three SNPs in or around RNF180 were genotyped in the
Swedish family material (Figure 1b). Genotyping analysis revealed
significant association between T1D and rs6880454 (p,0.01
Table 2).
Confirmation in Independent Cases and Controls
For confirmation of association, we genotypes markers in,
Danish families and two collections of sporadic Swedish T1D
cases; DISS2 and BDD material (Table 3).
In the Danish families, rs6295 showed modest association
(p,0.04). However, a stronger association was observed between
T1D and rs356570 (p,0.001). No individual SNP showed
association to T1D (Table 3, Figure 1b) in the Swedish DISS2
or BDD materials. Pooling of all four materials revealed that both
rs6295 and rs356570 were associated with T1D (p,0.01 and
p,0.003 respectively). Further, rs6880454 showed suggestive
association of p,0.05.
Two haplotypes in the HTR1A and RNF180 area in the Swedish
and Danish families; a haplotype containing rs6295 (C) – rs356570
(A) – rs6880454 (G) showed positive association to T1D (p,0.002
and p,0.05 respectively) while haplotype rs878567 (T)–
rs6449693 (G) – rs6295 (G) – rs356570 (G) showed protective
association (p,0.03 and p,0.02, Table 4). No haplotype
association was observed in the sporadic cases nor when all four
materials were pooled.
To see whether the two genes, HTR1A and RNF180 were
associated independently of each other, a conditional analysis was
performed. When the two family materials were pooled, the
rs6295 marker which maps close to HTR1A was associated
independently of markers in RNF180 (p,0.04). RNF180 showed
no association independently of HTR1A.
For HTR1A an analysis in the RAVEN program revealed that
the rs6295 SNP positioned next to the HTR1A gene is located in a
binding site for two transcription factors; Irf-1 and NRF-2.
Quantitative-PCR of HTR1A and RNF180 mRNA from
Human Islets of Langerhans
mRNA was isolated and converted to cDNA from a total of 10
healthy islet donors. Relative mRNA expression of HTR1A (n=6)
(Figure 3a) indicates expression of HTR1A in human islets of
Langerhans. Relative expression of RFN180 (n=4) was also
detected in human islet donors (Figure 3b).
HTR1A Protein in Human Beta Cells and Alpha Cells
Staining of human beta and alpha-cells was performed to
confirm results obtained from the q-PCR. Sections of human islets
and human pancreatic specimens were triple immunostained for
HTR1A, insulin and glucagon. This revealed that the HTR1A
receptor is mainly expressed in beta-cells and alpha-cells (Figure 4).
Importantly preabsorption with blocking peptide against HTR1A
blocked all staining in both isolated human islets and in islets of
human pancreatic sections (Figure 5).
Table 2. Association to the chromosome 5p13 region in Swedish multiplex/simplex families.
Marker name Location bp Minor Allele Minor allele frequency Call rate % p-value
rs1158292 63 001 317 A 0.38 93 0.2
rs1364043 63 266 735 G 0.22 89 0.03
rs970453 63 266 983 C 0.46 87 0.008
rs72767932 63 267 175 G 0.14 88 0.003
rs1423691 63 267 546 C 0.48 84 0.002
rs749099 63 269 720 T 0.45 94 0.02
rs749098 63 270 176 G 0.20 85 0.1
rs878567 63 271 875 C 0.50 91 0.06
rs6449693 63 271 902 A 0.50 95 0.1
rs6295 63 274 449 G 0.49 90 0.01
rs1364041 63 324 375 G 0.12 97 0.2
rs382098 63 310 581 C 0.48 89 0.08
rs749100 63 323 746 C 0.41 95 0.007
rs356562 63 346 993 A 0.4 95 0.001
rs356570 63 463 673 G 0.37 89 0.002
rs12697015 63 4886 95 C 0.15 98 0.3
rs6880454 63 502 802 T 0.08 95 0.01
rs11949052 63 532 300 A 0.14 98 0.4
SNP location (bp) was obtained from ‘‘HapMap Data Rel 19/phasell Oct 05, on NCBI B34 assembly, dbSNP b124’’ in HapMap.
Minor allele frequencies and p-values for the Swedish multiple/simplex families were obtained from Unphased v. 3.0.6. Hardy-Weinberg (H–W) values were calculated
amongst controls.
doi:10.1371/journal.pone.0035439.t002
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We have in a previous genome-wide linkage study observed
suggestive linkage of T1D to the 5p13-q13 region [4].
In previous reports several other autoimmune diseases such as
Crohn’s disease [17], Autoimmune Thyroid disease (AITD) [18],
Multiple Sclerosis (MS) [19], and Systemic lupus erythematosus
(SLE) [20], have all been linked to the chromosome 5 region.
Moreover, investigations indicate that IL7R which maps to the
chromosome 5p13 region is associated to T1D as well as MS [21],
[22].
The rs356570 SNP which is significantly associated to T1D in
our Swedish and Danish families tags for several SNPs in the
HTR1A and post RNF180 region. Also, two haplotypes showed
protective and positive association respectively in our families. No
single SNP or haplotype association was detected in the Swedish
sporadic cohorts. An explanation for this could be that there may
be heterogeneity between familial and sporadic cases due to an
enrichment of rare susceptibility genes with strong effect in the
family materials. In the Swedish sporadic materials common
susceptibility genes with low risk are likely to be more common.
Further, the difference in association may also be due to changes
in the environment. The multiplex families were collected a long
time ago and it may be that changes in susceptible environmental
factors have resulted in a change of importance of T1D
susceptibility genes as has been suggested by us previously [6].
HTR1A and RNF180 both show similar association to T1D in
the multiplex families. However, in a conditional analysis, the
HTR1A gene showed a slightly stronger association suggesting that
HTR1A is the main T1D gene in this region. It should also be
Figure 2. LD plot for HTR1A and RNF180. LD-block of the HTR1A and RNF180 regions was obtained from Haploview using HapMap data. The
linkage disequilbrium measure shown is r
2 and the block definition is solid spine defined by Gabriel et al., [35]. HTR1A and RNF180 are situated in two
separate blocks (r
2=0.91 between the two blocks). When LD for the two associated SNPs (rs356570 and rs6880454) is calculated we observe a D value
of 1 while r
2 is 0.021. The SNPs in bold were typed to verify the involvement of RNF180 to T1D susceptibility. Rs12697015 tags three other SNPs
located in the RNF180 downstream region. rs6880454 tags 17 additional SNPs on either side of RNF180. rs11949052 only tags for itself. Standard
settings were used for tagging anlysis in Haplowiev. The bold lines indicate the HTR1A sequenced area.
doi:10.1371/journal.pone.0035439.g002
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we have studied, our association cannot be due to IL7Rs
association to T1D (r
2,0.01 and D,0.02 between rs6897932 in
IL7R and rs356570 in HapMap data). Further, GWAS studies
performed by the Type 1 Diabetes Genetic Consortium (T1DGC)
[3] and Welcome Trust Case Control Consortium (WTCCC) [23]
do not detect any association of our studied region in their
materials. The genotyped markers in the WTCCC study included
our typed markers rs878567, rs382098 and rs356562 but not our
most associated marker rs356570 [23]. All typed markers are in
strong LD with each other (r
2,0.91). In the GWAS study
performed by WTCCC, sporadic rather than familial cases were
used. In our study we only detect significant association in family
materials. The use of sporadic versus familial cases may explain
the contradictory results in our and the WTCCC study.
Additionally, no SNPs which show association in our study were
genotyped in the T1DGC study. It would therefore be interesting
to genotype our studied SNPs in the multiplex T1DGC families to
test if the lack of confirming the association of HTR1A in sporadic
cases is due to a true heterogeneity between sporadic and
multiplex cases.
We observe association for the rs6295 SNP in the multiplex
families. Bioinformatic analysis indicate that rs6295 is located in a
binding site for at least two transcription factors; Irf-1 which plays
a role in regulating apoptosis and tumor suppression and NRF-2
which regulates cellular oxidative stress. It is therefore of interest to
test the effect of rs6295 on expression of HTR1A in order to
understand whether or not it is involved in the destruction of
pancreatic beta-cells.
There are seven different types of serotonin receptors [24]. It
has recently been reported that the HTR2A receptor is associated
with Rheumatoid Arthritis [25].
HTR1A is a relatively short intronless gene consisting of only 1
268 bp. The gene is known to encode for a G-protein coupled
receptor specific for serotonin which mediates cellular signaling via
the amine serotonin (5-HT) [26]. The HTR1A receptor is
expressed in many tissues but is mainly known to mediate signal
transduction in neurons in the central nervous system [27] where it
is involved in various complex behaviors such as appetite, sleep
and aggression. Changes in serotonin signaling are associated with
depression and suicide [28]. Expression of HTR1A has also been
reported throughout the enteric nervous system and in the
endocrine pancreas [29].
In the present study, we show that the 5-HTR1A protein is
present in human pancreatic beta and alpha-cells. In accordance,
we also show that HTR1A mRNA is expressed in human
pancreatic islets. This provides an important functional correlation
to the genetic data.
The neurotransmitter serotonin has been shown to be produced
in pancreatic islets of several different species [30] and in vitro
studies of rodent islet studies show that serotonin inhibits insulin
secretion [31]. Moreover, systemic activation of HTR1A with
sumatriptan in humans has a clear inhibitory effect on insulin
secretion [32]. Whether this is due to a regulation at a central level
or via a direct effect on the beta-cells, or both, remains to be
elucidated. Furthermore, during pancreas regeneration, the
expression of HTR1A is decreased while the insulin release is
Table 4. Haplotype association; Swedish – and Danish
families.
Family material Haplotype p-value
rs6295 -rs356570- rs6880454
Swedish families C-A-G 0.0013
Danish families C-A-G 0.048
rs878567-rs6449693-rs6295- rs356570
Swedish families T-G-G-G 0.025
Danish families T-G-G-G 0.018
doi:10.1371/journal.pone.0035439.t004
Figure 3. a-b. Q-PCR expression. Q-PCR expression for HTR1A (a)
and RNF180 (b) from mRNA isolated from a total of 10 human islet
donors. Data is presented as means of expression relative to the
housekeeping genes cyclophilin A (PPIA), polymerase 2 (POL2A) and
hypoxanthine guanine phosphoribosyl transferase (HPRT) +/2 SEM.
doi:10.1371/journal.pone.0035439.g003
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PLoS ONE | www.plosone.org 8 May 2012 | Volume 7 | Issue 5 | e35439increased [33]. From this, it may be speculated that different
HTR1A genotypes affects insulin release and could thereby be
involved in the development of T1D. HTR1A has also been
reported to play a role in the immune system. It has been reported
that activated T-cells express high amounts of HTR1A while
resting T-cells have low HTR1A expression [34]. Further, HTR1A
is known to down regulate adenylate cyclase which in turn
regulates T-cell functions such as production of IL-2 and cytotoxic
T-cell activity [34]. Hence polymorphisms in the HTR1A gene
may also affect the T-cell activity and thereby influencing the risk
of developing T1D.
As mentioned earlier, two haplotypes containing rs356570
which maps upstream of both HTR1A and RNF180 were
identified in this study. It is therefore possible that a
Figure 4. Human isolated islets and human pancreas triple immunostained for HTR1A, insulin and glucagon. Human isolated islets (A–
D) and human pancreas (E–H) triple immunostained for HTR1A (A, E), insulin (B, F), and glucagon (C,G); merged in D and H. Arrow heads indicate beta
cells with HTR1A immunoreactivity, arrows indicate alpha cells with HTR1A immunoreactivity. Scale bar=20 um in A for upper panel, in E for lower
panel.
doi:10.1371/journal.pone.0035439.g004
Figure 5. Human isolated islets and human pancreas with HTR1A antibodies preabsorbed with blocking peptide against HTR1A.
Human isolated islets (A–B) and human pancreas (C–D). A and C immunostained for HTR1A. B and D the same islets as in A and C in consecutive
sections immunstained with HTR1A antibodies preabsorbed with blocking peptide against HTR1A, demonstrating complete lack of immunoreaction.
Scale bar=50 um in A for upper panel, in 25 um in C for lower panel.
doi:10.1371/journal.pone.0035439.g005
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PLoS ONE | www.plosone.org 9 May 2012 | Volume 7 | Issue 5 | e35439polymorphism in this region effects the expression of both
HTR1A and RNF180. Since we in this study observe that
HTR1A might be involved in T1D susceptibility independently
of RNF180, we suggest that expression studies of HTR1A should
be carried out in order to fully understand its function in T1D
development. Also, further SNP genotyping in large case-control
studies and sequencing should be carried out to confirm the
association and determine which SNP in and around HTR1A is
the main T1D associated marker.
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[4] and fine mapping. Typed microsatellites in the original scan
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